The Multiple System Atrophy (MSA) Coalition, the leading nonprofit funder of global MSA research, announced that the organization has reached the milestone of investing more than $3.5 million in total MSA research funding since 2013. The MSA Coalition distributes funds to encourage and finance critically important MSA research leading to the identification of causes, improved diagnostic methods, and more effective symptomatic and disease modifying treatments.
MCLEAN, Va., Dec. 14, 2022 /PRNewswire-PRWeb/ -- The Multiple System Atrophy (MSA) Coalition, the leading nonprofit funder of global MSA research, announced that the organization has reached the milestone of investing more than $3.5 million in total MSA research funding since 2013.
The Multiple System Atrophy Coalition distributes funds to encourage and finance critically important MSA research leading to the identification of causes, improved diagnostic methods, and more effective symptomatic and disease modifying treatments.
The funds have gone toward more than 55 projects at 35 research centers in 12 countries, which continues the history of alignment with the vision of the Global MSA Research Roadmap established in 2014.
"The grants support a large diversity of basic and clinical research conducted by the best primary investigators on the globe committed to find a cure for MSA," said Gregor Wenning, MD, PhD, and Research Liaison on the Board of Directors of the MSA Coalition. "Let`s continue on this highly successful path."
In 2022, the MSA Coalition supported seven new clinical, pre-clinical, biomarker, and pathogenesis studies at institutions around the world.
"We are so grateful for every dollar that the MSA Coalition has raised and are proud of the amazing work that is being done," said Joe Lindahl, MA, CAE, Executive Director of the MSA Coalition. "MSA patients and their families depend on research that is being done to eventually improve their lives with more effective treatments. Every project that we fund brings us closer to finding a cure for this detrimental disease."
MSA is a rare neurodegenerative disorder that can cause a multitude of symptoms in any combination including impairments to balance, difficulty with movement, poor coordination, bladder dysfunction, sleep disturbances and poor blood pressure control. There is currently no cure for MSA.
The Seed Grant application for 2023 will open February 1.
For more information on MSA or the work that the MSA Coalition is doing, visit multiplesystematrophy.org.
Media Contact
Joe Lindahl, Executive Director, MSA Coalition, +1 866-737-5999, [email protected]
SOURCE MSA Coalition
Share this article